Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | 1,4-Dioxane | HCID 31275 | — |
| Reactant | 5-Bromo-2-methoxypyrimidin-4-amine | HCID 45789781 | — |
| Reactant | 4-(Tetramethyl-1,3,2-dioxaborolan-2-yl)-6-(trifluoromethyl)-1H-indazole | HCID 89782806 | — |
| Catalyst | Bis(cyclopenta-1,4-dien-1-yl(diphenyl)phosphane);dichloropalladium;iron(2+) | HCID 178418228 | — |
| Solvent | Sodium Bicarbonate | HCID 516892 | — |
| Product | Trifluoroacetic acid | HCID 6422 | — |
| Product | HCID 89783083 | HCID 89783083 | 29% |
Reaction Steps
A vial was charged with a mixture of 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-6-(trifluoromethyl)-1H-indazole (0.1 g, 0.320 mmol), 5-bromo-2-methoxypyrimidin-4-amine (0.131 g, 0.641 mmol) and PdCl2(dppf) (0.012 g, 0.016 mmol) in dioxane (8 mL) and aqueous saturated NaHCO3 (2 mL). The resulting light brown suspension was heated at 140° C. for 45 minutes in a microwave reactor. The reaction mixture was subsequently concentrated and the crude residue was purified by preparative HPLC, eluting with a gradient of 15-25% ACN (containing 0.035% TFA) in H2O (containing 0.05% TFA) over a period of 5 minutes. The product-containing fractions were combined and volatiles were removed in vacuo to give a TFA salt of the title compound as light brown solid (0.029 g, 29%). 1H NMR (400 MHz, DMSO-d6) δ ppm 4.04 (s, 3H), 7.35-7.41 (m, 1H), 8.03 (s, 1H), 8.06-8.15 (m, 1H), 8.21 (s, 1H); ESI-MS m/z [M+H]+ calc'd for C13H10F3N5O, 310.1. found 310.13.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US09434743B2 |
|---|
| Source dataset | uspto-grants-2016_09 |
|---|
| ORD ID | ord-8160efd0d9d64d4487637fd15c8519b7 |
|---|
| Source note | uspto-grants-2016_09 |
|---|